Randomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific rationale and study design.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples